Case number 1:17-cv-01361
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (12) |
| Jul 24, 2018 | 21 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Numbers 6,509,376 ;7,320,999. (etg) |
| May 16, 2018 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 99 in Lead Case No. 17-823-LPS) Modified on 5/16/2018 (ntl). |
| Feb 2, 2018 | N/A | Create Case Association (0) |
| Feb 2, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00824-LPS et al.(dlb) |
| Feb 2, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-00823-LPS. (ntl) |
| Jan 31, 2018 | 20 | Proposed Order (22) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Jan 31, 2018 | 19 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven) |
| Jan 23, 2018 | 18 | Transcript (35) Docket Text: Official Transcript of Scheduling Telephone Conference held on January 17, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/13/2018. Redacted Transcript Deadline set for 2/23/2018. Release of Transcript Restriction set for 4/23/2018.(bpg) |
| Jan 17, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 1/17/2018. (Court Reporter B. Gaffigan.) Associated Cases: 1:17-cv-00823-LPS et al. (ntl) |
| Jan 10, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney Elizabeth J. Holland, Huiya Wu, Samuel Sherry, Todd Marabella and Naomi L. Birbach filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 1/10/18. (ntl) |
| Jan 9, 2018 | 17 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elizabeth J. Holland, Huiya Wu, Samuel Sherry, Todd Marabella and Naomi L. Birbach - filed by Teva Pharmaceuticals USA, Inc.. (Wilson, Samantha) |
| Dec 28, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for January 17, 2018 at 9:30 AM. Plaintiffs counsel shall initiate the teleconference call to 302-573-4571. No further submissions are necessary. ORDERED by Judge Leonard P. Stark on 12/28/2017. Associated Cases: 1:17-cv-00823-LPS et al.(etg) |
| Dec 20, 2017 | N/A | SO ORDERED (0) |
| Dec 20, 2017 | 15 | Proposed Order (25) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Dec 20, 2017 | 14 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven) |
| Dec 15, 2017 | 13 | Stipulation (12) Docket Text: STIPULATION Seeking to Extend the Deadline by Which the Parties Must Submit a Proposed Scheduling Order, by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Nov 29, 2017 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than December 15, 2017. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 11/29/17. Associated Cases: 1:17-cv-00823-LPS et al. (ntl) |
| Nov 13, 2017 | 11 | Answer to Counterclaim (5) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Biogen International GmbH.(Mayo, Andrew) |
| Nov 7, 2017 | N/A | SO ORDERED (0) |
| Nov 6, 2017 | 10 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Defendants' Counterclaims to November 13, 2017 - filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew) |
| Nov 1, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Li Feng for Biogen International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg) |
| Oct 19, 2017 | 9 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries, Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Wilson, Samantha) |
| Oct 19, 2017 | 8 | Answer to Complaint (19) Docket Text: ANSWER to [1] Complaint, Defenses, COUNTERCLAIM against Biogen International GmbH by Teva Pharmaceuticals USA, Inc..(Wilson, Samantha) |
| Oct 19, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 19, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 19, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 13, 2017 | N/A | SO ORDERED (0) |
| Oct 12, 2017 | 7 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Sanya Sukduang, Li Feng, and Andrew E. Renison - filed by Biogen International GmbH. (Mayo, Andrew) |
| Oct 4, 2017 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc., Corporate Parent Biogen MA Inc., Corporate Parent Biogen Luxembourg Holding Sarl, Corporate Parent Biogen Switzerland Holdings GmbH for Biogen International GmbH filed by Biogen International GmbH. (Mayo, Andrew) |
| Oct 4, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Sep 28, 2017 | 5 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Biogen International GmbH. Teva Pharmaceuticals USA, Inc. served on 9/28/2017, answer due 10/19/2017. (Mayo, Andrew) |
| Sep 28, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 9/28/2017. (nmfn) |
| Sep 28, 2017 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmfn) |
| Sep 27, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,509,376; 7,320,999. (nmfn) |
| Sep 27, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/21/2017. Date of Expiration of '376 Patent: 10/29/2019. Expiration of '999 Patent: 5/18/2020. Thirty Month Stay Deadline: 9/27/2020. (nmfn) |
| Sep 27, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Sep 27, 2017 | 1 | Civil Cover Sheet (4) |
| Sep 27, 2017 | 1 | Exhibit B (8) |
| Sep 27, 2017 | 1 | Exhibit A (7) |
| Sep 27, 2017 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2233500.) - filed by Biogen International GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(nmfn) |
| Sep 27, 2017 | 1 | Complaint* (1) |
